Table 5.
Testing combination | Pre-protocol time period | Post-protocol time period | ||||
---|---|---|---|---|---|---|
n | Diagnosis from Testing | Cost | n | Diagnosis from Testing | Cost | |
Karyotype + 22q + CMA | 111 | 18 | $464,048.82 | 0 | 0 | 0 |
Karyotype + 22q | 59 | 4 | $92,340.31 | 0 | 0 | 0 |
Karyotype + CMA | 81 | 24 | $284,391.00 | 12 | 6 | $42,132.00 |
QPCR + CMA | 39 | 9 | $128,124.75 | 17 | 3 | $55,849.25 |
Karyotype only | 56 | 33 | $50,129.52 | 21 | 21 | $18,798.57 |
22q only | 34 | 2 | $21,290.18 | 6 | 4 | $4,019.52 |
CMA only | 61 | 15 | $159,535.13 | 65 | 12 | $169,996.45 |
Patients tested | 441 | 105 | $1,199,859.71 | 121 | 46 | $290,795.79 |
Patients untested | 292 | 0 | $0 | 37 | 0 | $0 |
Total | 733 | 105 | $1,199,859.71 | 158 | 46 | $290,795.79 |
Average Cost per Tested Patients | $2720.77 | $2403.27 | ||||
Average Cost per Diagnosis | $11,427.24 | $6321.65 |
This table demonstrates the pre-protocol testing patterns and associated cost to the patient in addition to the number of genetic diagnoses made by the test specified. The bolded number reflect total average cost per tested patient and total cost per diagnosis for the two time periods. This demonstrates a post-protocol reduction in average cost per patient who underwent genetic testing by $317.50 and a post-protocol reduction on average cost per diagnosis by $5105.59. CMA Chromosomal Microarray, 22q = 22q11.2 deletion testing